ALK sequence mutations have been reported in approximately 5–10% of neuroblastomas [7], [10]–[12], and these predominantly occur within the tyrosine kinase domain, the two hotspots being p.F1174 and p.R1275 [13]. This evidence concerns the gene ALK and neuroblastoma.